Join Richmond Pharmacology at this year's 10th Annual Congress of the European Association for Clinical Pharmacology

Posted:
16
May 2011

Join Richmond Pharmacology at this year s 10th Annual Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), taking place on June 26-29 in Budapest, Hungary.The Congress will focus on key research and therapeutic areas, related challenges and latest achievements with the help of distinguished invited speakers, opinion leaders, experts and the upcoming future generation of clinical pharmacologists.We invite all attendees to join Richmond Pharmacology s Medical Director and Co-Founder Dr Ulrike Lorch at her presentation titled  frThe Use of Adaptive Study Design in Early Phase Clinical Research  scheduled for Day one, Session one at 10am.  For the full Scientific Programme of EACPT Congress please click here.In the last several years the interest in Adgaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr Lorch s presentation will describe where this design is of benefit to the conduct of First into Human and Early Phase Combination Studies and compare adaptive and conventional study design.  Little has been published on the practical application and merits of adaptive study design in Early Phase Clinical Research, so this presentation offers attendees a chance to learn more about the subject.If you would like to meet with Dr Ulrike Lorch, Richmond Pharmacology s CEO Dr Jorg Taubel.In the last several years the interest in Adaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr Lorchinfo@richmondpharmacology.com in advance to arrange a face-to-face meeting and discuss how Richmond Pharmacology can assist you with your current challenges.We hope to see you in Budapest to learn more about Richmond Pharmacology and enjoy one of Europe�s most lively cultural destinations.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more